Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R F Barth

Showing results (61-70 of 152) with videos related to

Pageof 16
Sort By:
Hybridoma|October 1, 1992
Lack of effect of recombinant human interferon-alpha 2b on expression of 17-1A antigen on human colon cancer cellsO A Oredipe, R F Barth, J H Rotaru, et al.
Research Communications in Chemical Pathology and Pharmacology|September 1, 1989
Chemopreventative activity of dietary glucarate on azoxymethane-induced altered hepatic foci in ratsO A Oredipe, R F Barth, C Dwivedi, et al.
Cancer Research|May 1, 1991
Phenotype and functional activity of tumor-infiltrating lymphocytes isolated from immunogenic and nonimmunogenic rat brain tumorsJ J Tzeng, R F Barth, C G Orosz, et al.
Cancer|December 15, 1992
Boron neutron capture therapy for cancer. Realities and prospectsR F Barth, A H Soloway, R G Fairchild, et al.
American Heart Journal|January 1, 1971
Antilymphocyte serum blockade of the reticuloendothelial systemM D Sheagren, J B Edelin, R F Barth, et al.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|November 1, 1984
Injection of cells and monoclonal antibodies into mice: comparison of tail vein and retroorbital routesJ E Price, R F Barth, C W Johnson, et al.
Cancer Research|July 15, 1990
Adoptive immunotherapy of a rat glioma using lymphokine-activated killer cells and interleukin 2J J Tzeng, R F Barth, N R Clendenon, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1970
Mechanism of reticuloendothelial system blockade produced by antilymphocyte serumJ N Sheagren, R F Barth, J B Edelin, et al.
Transplantation Proceedings|March 1, 1971
Enhanced antibody production to type III pneumococcal polysaccharide in mice treated with antilymphocyte serum: evidence for cellular regulatory mechanism of IgM antibody responseR F Barth, P J Baker, P W Stashak, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1970
Enhancement of the antibody response to type 3 pneumococcal polysaccharide in mice treated with antilymphocyte serumP J Baker, R F Barth, P W Stashak, et al.
Pageof 16

Showing results (61-70 of 152) with videos related to

Sort By:
Pageof 16
Hybridoma|October 1, 1992
Lack of effect of recombinant human interferon-alpha 2b on expression of 17-1A antigen on human colon cancer cellsO A Oredipe, R F Barth, J H Rotaru, et al.
Research Communications in Chemical Pathology and Pharmacology|September 1, 1989
Chemopreventative activity of dietary glucarate on azoxymethane-induced altered hepatic foci in ratsO A Oredipe, R F Barth, C Dwivedi, et al.
Cancer Research|May 1, 1991
Phenotype and functional activity of tumor-infiltrating lymphocytes isolated from immunogenic and nonimmunogenic rat brain tumorsJ J Tzeng, R F Barth, C G Orosz, et al.
Cancer|December 15, 1992
Boron neutron capture therapy for cancer. Realities and prospectsR F Barth, A H Soloway, R G Fairchild, et al.
American Heart Journal|January 1, 1971
Antilymphocyte serum blockade of the reticuloendothelial systemM D Sheagren, J B Edelin, R F Barth, et al.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|November 1, 1984
Injection of cells and monoclonal antibodies into mice: comparison of tail vein and retroorbital routesJ E Price, R F Barth, C W Johnson, et al.
Cancer Research|July 15, 1990
Adoptive immunotherapy of a rat glioma using lymphokine-activated killer cells and interleukin 2J J Tzeng, R F Barth, N R Clendenon, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1970
Mechanism of reticuloendothelial system blockade produced by antilymphocyte serumJ N Sheagren, R F Barth, J B Edelin, et al.
Transplantation Proceedings|March 1, 1971
Enhanced antibody production to type III pneumococcal polysaccharide in mice treated with antilymphocyte serum: evidence for cellular regulatory mechanism of IgM antibody responseR F Barth, P J Baker, P W Stashak, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1970
Enhancement of the antibody response to type 3 pneumococcal polysaccharide in mice treated with antilymphocyte serumP J Baker, R F Barth, P W Stashak, et al.
Pageof 16